Activation of corticostriatal pathway leads to similar morphological changes observed following haloperidol treatment

Synapse

Volumn 22, Issue 4, 1996, Pages 350-361

  Meshul, Charles K ^a,b   Buckman, Jennifer F ^a   Allen, Cynthia ^a   Riggan, John P ^a   Feller, Daniel J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Glutamate; Haloperidol; Immunocytochemistry; Microdialysis; Perforated PSD; Striatum; Synaptic plasticity

Indexed keywords

GLUTAMIC ACID; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE RECEPTOR BLOCKING; DRUG EFFECT; DRUG RECEPTOR BINDING; EXCITATORY POSTSYNAPTIC POTENTIAL; EXTRAPYRAMIDAL SYSTEM; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; GAMMA-AMINOBUTYRIC ACID; HALOPERIDOL; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; NEURAL PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; TIME FACTORS;

EID: 0029864021     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199604)22:4<350::AID-SYN6>3.0.CO;2-A     Document Type: Article

References (47)

1. Barbeito, L., Girault. J.A., Godeheu, G., Pittaluga, A., Glowinski, J., and Cheramy, A. (1989) Activation of the bilateral corticostriatal glutamatergic projection by infusion of GABA into thalamic motor nuclei in the cat: An in vivo release study. Neuroscience, 28:365-374.
2. 2) receptors: A study of the actions of dopamine on corticostriatal transmission. Neuroscience, 10:349-355.
3. Burt, D., Creese, I., and Snyder, S. (1977) Antischizophremc drugs: Treatment elevates dopamine receptor binding in brain, Science, 196:326-328.
4. Calabresi, P., De Murtas, M., Mercuri, N.B., and Bernardi, G. (1992a) Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. Ann. Neurol., 31.366-373.
5. Calabresi, P., Pisani, A., Mercuri, N.B., and Bernardi, G. (1992b) Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels. Eur J Neurosci., 4:929-935.
6. Chiodo, L.A., and Bunney, B.S. (1983) Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci., 3:1607-1619.
7. De Keyser, J. (1991) Excitotixic mechanisms may be involved in the pathophysiology of tardive dyskinesia. Clin. Neuropharm., 14:562-565.
8. Di Chiara, G., Morelli, M., and Consolo, S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NTMDA interactions. Trends Neurosci., 17:228-233.
9. Einot, I., and Gabriel, K. (1975) A study of the powers of several members of multiple comparisons. J. Am. Stat. Assoc., 70:574-583.
10. 2+/ calmodulin-dependent protein kinase II. J. Biol. Chem., 268 7863-7867.
11. Garau, L., Govoni, S.S., Stefanini, E., Trabucchi, M., and Spano P.F. (1978) Dopamine receptors: Pharmacological and anatomical evidences indicate that two distinct populations are present in rat striatum. Life Sci., 23:1745-1750.
12. Garcia-Munoz, M., Young, S.J., and Groves, P.M. (1991) Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation. Brain Res., 551:195-206.
13. Garcia-Munoz, M., Young, S.J., and Groves, P.M. (1992) Presynaptic long-term changes in excitability of the corticostriatal pathway. Neuroreport, 3:357-360.
14. Geinisman, Y., de Toledo-Morrell, L. and Morrell, F. (1991) Induction of long-term potentiation is associated with an increase in the number of axospinous synapses with segmented postsynaptic densities. Brain Res., 566:77-88.
15. Godukhin, O. V., Zharikova, A.D. and Novoselov, V.I. (1980) The release of labeled L-glutamic acid from rat neostriatum in vivo following stimulation of frontal cortex. Neuroscience, 5:2151-2154.
16. Greenough, W.T., West, R.W., and DeVoogd, T.J. (1978) Subsynaptic plate perforations: Changes with age and experience in the rat. Science, 202:1096-1098.
17. Gundersen, V., Ottersen, O.P., and Storm-Mathisen, J. (1991) Aspartate-and glutamate-like immunoreactivities in rat hippocampal slices: Depolarization-induced redistribution and effects of precursors. Eur. J. Neurosci., 3:1281-1299.
18. Gunne, L.M., and Andren, P.E. (1993) An animal model for coexisting tardive dyskinesia and tardive parkinsonism: A glutamate hypothesis for tardive dyskinesia. Clin. Neuropharmacol. 16:90-95.
19. Hepler, J.R., Toomim, O.S., McCarthy, K.D., Conti, F., Battaglia, G., Rustioni, A., and Petrusz, P. (1988) Characterization of antisera to glutamate and aspartate. J. Histochem. Cytochem., 36:13-22.
20. 2 sites in rat caudate-putamen: Localization to intrinsic neurons and not to neocortical afferents. Neuroseience, 30:773-795.
21. Kerkerian, L., Dusticier, N., and Nieoullon, A. (1987) Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum. J. Neurochem., 48:1301-1306.
22. Lapper, S.R., and Bolam, J.P. (1992) Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat. Neuroseience, 51:533-545.
23. Maura, G., Giardi, A., and Raiteri, M. (1988) Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J. Phaemacol Exp. Ther , 247:680-684.
24. McMahon, H.T., and Nicholls, D.G. (1990) Glutamine and aspartate loading of synaptosomes: A reevaluation of effects on calcium-dependent excitatory amino acid release. J. Neurochem., 54:373-380.
25. Mennerick, S., and Zorumski, C.F. (1994) Glial contributions to excitatory neurotransmission in cultured hippocampal cells. Nature, 368:59-62.
26. Meshul, C.K., and Casey, D.E. (1989) Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment. Brain Res., 489:338-346.
27. Meshul, C.K., Janowsky, A , Casey, D.E., Stallbaumer, R.K., and Taylor, E. (1992a) Effect of haloperidol and clozapine on the density of 'perforated' synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology, 106:45-02.
28. Meshul, C.K., Janowsky, A., Casey, D.E., Stalibaumer, R.K., and Taylor, B. (1992b) Co-administration of haloperidol and SCH 23390 prevents the increase in 'perforated' synapses due to either drug alone. Neuropsychopharmacology, 7:285-293.
29. Meshul, C.K., Stallbaumer, R.K., Taylor, B., and Janowsky, A. (1994) Haloperidol-induced morphological changes in striatum are associated with glutamate synapses. Brain Res., 648:181-195.
30. Meshul, C.K., and Tan, S.E. (1994) Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity. Synapse, 18: 205-217.
31. 3H]glutamic acid release by dopaminergic drugs. Life Sci., 26:2073-2081.
32. Nieoullon, A., Kerkerian, L., and Dusticier, N. (1983) Presynaptic dopaminergic control of high affinity glutamate uptake in the striatum. Neurosci. Lett., 43:191-196.
33. Nicholls, D., and Attwell, D. (1990) The release and uptake of excitatory amino acids. Trends Neurosci., 11:462-468.
34. Ottersen, O.P., Storm-Mathisen, J., Bramham, C., Torp, R., Laake, J., and Gundersen, V. (1990) A quantitative electron microscopic immunocytochemical study of the distribution and synaptic handling of glutamate in rat hippocampus. Prog. Brain Res., 83:99-114.
35. Palmer, A.M., Hutson, P.H., Lowe, S.L., and Bowen, D.M. (1989) Extracellular concentrations of aspartate and glutamate in rat neostriatum following chemical stimulation of frontal cortex. Exp. Brain Res., 75:659-663.
36. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd Ed. Academic Press, San Diego, CA.
37. Phead, K.D., Weinberg, R.J., and Rustioni, A. (1992) Techniques to optimize post-embedding single and double staining for amino acid neurotransmitters. J. Histochem. Cytochem., 40:1011-1020.
38. Robinson, T.E., and Wishaw, I.Q. (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats. Brain Res., 450:209-224.
39. Romo, R., Cheramy, A., Godeheu, G., and Glowinski, J. (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus-1: Opposite changes in neuronal activity and release evoked from thalamic motor nuclei. Neuroscience, 19:1067-1079.
40. Rowlands, G. J., and Roberts, P. J. (1980) Activation of dopamine receptors inhibits calcium-dependent glutamate release from corticostriatal terminals in vitro. Eur. J. Pharmacol., 62:241-242.
41. Schuster, R (1988) Determination of amino acids in biological, pharmaceutical, plant and food samples by automated precommn derivatization and high-performance liquid chromatography. J. Chromatog., 431:271-284.
42. Schwarcz, R., Creese, I., Coyle, J.T., and Snyder, S.H. (1978) Dopamine receptors localized on cerebral cortical afferents to corpus striatum. Nature, 271.766-768.
43. See, R.E., and Chapman, M.A. (1994) Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. Eur. J. Pharm., 263:269-276.
44. Streit, P. (1980) Selective retrograde labelling indicating the transmitter of neuronal pathways. J. Comp. Neurol., 191:429-463.
45. Walsh, J.P., and Dunia, R. (1993) Synaptic activation of N-methyl-D-aspartate receptors induces short-term potentiation at excitatory synapses in the striatum of the rat. Neuroscience, 57:241-248.
46. Yamamoto, B.K., and Cooperman, M.A. (1994) Differential effects of chronic antipsychotie drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci., 14:4159-4166.
47. Yamamoto, B.K., and Davy, S. (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem., 58:1736-1742.